0001209191-17-022141.txt : 20170321 0001209191-17-022141.hdr.sgml : 20170321 20170321200952 ACCESSION NUMBER: 0001209191-17-022141 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170320 FILED AS OF DATE: 20170321 DATE AS OF CHANGE: 20170321 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cascadian Therapeutics, Inc. CENTRAL INDEX KEY: 0001412067 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 260868560 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2601 FOURTH AVENUE STREET 2: SUITE 500 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: (206) 801-2100 MAIL ADDRESS: STREET 1: 2601 FOURTH AVENUE STREET 2: SUITE 500 CITY: SEATTLE STATE: WA ZIP: 98121 FORMER COMPANY: FORMER CONFORMED NAME: Oncothyreon Inc. DATE OF NAME CHANGE: 20070927 FORMER COMPANY: FORMER CONFORMED NAME: Biomira CORP DATE OF NAME CHANGE: 20070911 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Myers Scott Dunseth CENTRAL INDEX KEY: 0001356256 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33882 FILM NUMBER: 17705333 MAIL ADDRESS: STREET 1: C/O ONOTHYREON INC. STREET 2: 2601 4TH AVENUE, SUITE 500 CITY: SEATTLE STATE: WA ZIP: 98121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-03-20 0 0001412067 Cascadian Therapeutics, Inc. CASC 0001356256 Myers Scott Dunseth C/O CASCADIAN THERAPEUTICS, INC. 2601 4TH AVE., SUITE 500 SEATTLE WA 98121 1 1 0 0 President and CEO Common Stock 2017-03-20 4 P 0 1000 3.9271 A 39416 D /s/ Julia M. Eastland as attorney-in-fact for Scott D. Myers 2017-03-21